A new disease-modifying antirheumatic drug (DMARD) was developed. | Medibuddy
Login Sign up
Close
Undergraduate Year 1 Undergraduate Year 2 Exams MLA ST1 / CT / ACCS Interviews ST3 Interviews ST4 Interviews Crash Courses Professional Development
15th February 2024

A new disease-modifying antirheumatic drug (DMARD) was developed.

A new disease-modifying antirheumatic drug (DMARD) was developed. Researchers have conducted a study where a group of patients with rheumatoid arthritis was given this medication with a separate group of patients given methotrexate. The DAS-28 score was used to calculate the patient’s symptom severity in both groups. 

Which statistical test is most appropriate to identify a significant difference between the two groups?

Complete Guide to Clinical Genetics ST3 Application and Recruitment (2027)

Written by Medibuddy. Last updated: October 2026. Clinical Genetics is

Clinical Genetics ST3

Complete Guide to Clinical Radiology ST3 Application and Recruitment (2027)

Recruitment paused: NHS England is not running Clinical Radiology ST3+ recru

Clinical Radiology ST3

Complete Guide to Paediatric Surgery ST3 Application and Recruitment in United Kingdom (2026)

Written by Medibuddy. Last updated: October 2026. If you’re planning

Paediatric Surgery ST3
Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.